InvestSMART

HeraMED Limited (ASX:HMD)

ALERT: Price-sensitive ASX Announcement for HMD
Current share price for HMD : $0.038 -0.005 (-11.63%)+
Announcement
Release
27 Jan 2026 10:02AM
Price at Release
$0.043
Full Release
download
Summary
HeraMED Limited announced it has successfully raised A$3.2 million through a two-tranche placement of 80 million fully paid ordinary shares, each priced at $0.04, which represents a 7.0% discount on the last traded price. The placement attracted new institutional and sophisticated investors, along with support from existing shareholders. The funds raised will be used to support and accelerate commercial deployments, pilots, and integration of the HeraCARE platform across large health systems in the US, Australia, and Europe. This initiative aims to fortify HeraMED's position in the digital maternity care market. The placement was managed by Westar Capital Limited and Shares in Value Pty Ltd, with Candour Advisory Pty Ltd as co-manager. The first tranche of shares is scheduled for settlement and trading in early February, while the second tranche is pending shareholder approval in March.
Key Points
  • HeraMED Limited raises A$3.2 million via a two-tranche placement.
  • 80 million new shares issued at $0.04 each, a 7.0% discount.
  • Funds to enhance commercial deployments and platform integration.
  • New and existing investors participated in the placement.
  • Westar Capital Limited and Shares in Value Pty Ltd led the placement.
  • First tranche set for February, second tranche pending March approval.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.